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ScienceDirectRecent progress in interpreting comprehensive genetic and
epigenetic profiles for human cellular states has contributed
new insights into the developmental origins of disease,
elucidated novel signalling pathways and enhanced drug
discovery programs. A similar comprehensive approach to
decoding the epigenetic readouts from chemical challenges
in vivo would yield new paradigms for monitoring and assessing
environmental exposure in model systems and humans.
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DNA methylation dynamics in the genome
Epigenomic profiling of multiple tissues and many dis-
ease states has enhanced drug discovery programs, cancer
diagnosis and analysis, population based studies and
regenerative medicine. The relative ease of genomic
mapping of DNA methylation was facilitated by an
epigenetic mark that is highly stable and can be retrieved
from archival samples [1–4]. Genomic DNA methylation
profiles are tissue specific hallmarks of cell identity [5].
The modification occurs at the 5th position of cytosine to
generate 5-methylcytosine (5mC), typically in the con-
text of the dinucleotide CpG on both DNA strands. In
somatic tissues >70% of CpGs are constitutively methyl-
ated [6]. The propagation and maintenance of DNA
methylation patterns during development, by combinedCurrent Opinion in Chemical Biology 2018, 45:48–56 action of DNA methyltransferases (DNMTs) and DNA
demethylation pathways, creates an epigenetic ‘landscape’
that supports cell type specific gene regulatory networks,
regulates imprinted gene activity, represses transposon
activity and enhances genome integrity [6].
DNA methylation is an epigenetic repressive mark in
regulatory regions (gene promoters and enhancers), gen-
erally associated with their functional inhibition as deter-
mined by sequence context [6,7]. DNA methylation
reprogramming can result from inhibition of DNMTs
or de novo DNMT activity. In addition, TET enzymes
contribute to DNA methylation dynamics by oxidation of
5mC to 5-hydroxymethylcytosine (5hmC), 5-formylcyto-
sine (5fC) and 5-carboxylcytosine (5caC) as intermediates
in DNA demethylation pathways. These additional DNA
modifications may also act as unique epigenetic signals
(Figure 1a) [8]. Although 5hmC, 5fC and 5caC are less
abundant than 5mC, they contribute to a sensitive and
dynamic read-out of cell state, as their profiles are in part
determined by active gene-body transcription and
enhancer activity, which are rapidly altered upon envi-
ronmental challenge [8,9,10]. 5mC profiles can exhibit
age associated changes that may predicate more dramatic
changes upon cellular transformation [11] (Figure 1b).
Conversely, 5hmC profiles, in concert with other epige-
nomic profiles, are a highly useful tool for charting envi-
ronmental exposure and integrated pathway analysis to
reveal a drug’s mode of action (MoA) [12] (Figure 2).
DNA modification ‘barcoding’ in risk
assessment
In an environmental exposure context, a baseline of
epigenomic profiles (including transcription) for the tar-
get tissue in the organism can be used as a starting point
for dose–response, temporal and transient exposure stud-
ies with model compounds (inorganic Arsenic, Vinclozo-
lin and Triclosan) (Figure 2) [13]. It is essential to use
models that can be extrapolated to humans, as responses
to a drug or environmental challenge may be species
specific [13]. Furthermore environmental epigenetics
has to be allied with classical toxicology studies in order
to be fully informative [14,15]
Elucidating the xenobiotic-induced physiological
changes in animal models and human cohorts is important
for hazard (including cancer) identification and risk assess-
ment [13,16]. Concern over bio-reactive chemical andwww.sciencedirect.com
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Figure 1
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The methylome as a marker of cell state. (a) In the proposed mammalian DNA methylation pathway, canonical methylcytosine (5mC) is formed by
addition of a methyl group to unmodified cytosine by DNA methyltransferase enzymes (DNMTs). Members of the TET family of di-oxygenases can
then convert 5mC to 5-hydroxymethylcytosine (5hmC), using iron and a-ketoglutarate as cofactors. The DNA methylation cycle is completed by
conversion of 5hmC to unmodified cytosine by (i) passive de-methylation upon DNA replication as methyltransferases do not recognise
hydroxymethylated DNA, or (ii) TET-mediated oxidation of 5hmC to 5-formylcytosine (5fC) and then carboxyl-cytosine (5caC), followed by their
removal through base-excision repair. (b) The development of epigenetic identity in mammalian cells reflects the establishment and activity of
underlying gene regulatory networks (GRNs) that specify epigenetic transitions in dynamic and reversible systems that become more restricted as
development proceeds.environmental agents has led to better understanding of
the MoAs underlying toxic effects of chemical exposure
[17]. Testing of chemicals depends on long-term rodent
bioassays, which are costly and time-consuming, especially
dose response studies to evaluate minimal observed
adverse effect levels as points of departure (PoD) for
hazard assessment. Recent progress has demonstrated that
the integrated analysis of combined gene expression and
epigenetic profiling of target tissues in model organisms
exposed to chemical compounds can reveal underlying
MoAs, and may act as predictors of atypical endpoints
and adverse outcome pathways (AOPs) where cellular
homeostasis is over-ridden [18,19]. The application of
epigenomics profiling in concert with bioassays can further
inform decisions in chemical risk assessment by identify-
ing the critically sensitive biological pathways. As epige-
nomic signatures can be propagated through cell divisions,
they can potentially persist even after removal of the
exposure agent [20]. However, altered epigenomic profiles
may also signify changes in cellular populations, altered by
exposure [3]. This record of chronic epigenomic alterations
induced by multiple environmental exposures may be
interpreted in terms of a ‘barcode/identifier’ of risk and
consequences that can be developed into alternative
screening systems, such as microfluidic organs-on-a-chip
technologies [20,21].
5hmC mapping: a tool to link exposure events
to disease states
A wealth of data has recorded changes in transcriptional
states following compound exposure [22]. However, due
to the highly dynamic nature of transcriptional changes
following chemical exposure, it is challenging to tell causewww.sciencedirect.com from effect in these studies. The application of dynamic
5hmC profiling can enhance the information extracted
from exposure studies, especially if it can be performed
on archived material and integrated with previous data
profiles. 5hmC patterns are linked with gene expression
status and can rapidly alter following short term (24 hours)
exposure — highlighting the sensitivity of such assays
[9]. 5hmC alterations are linked to the length of drug
exposure, and a number of 5hmC changes induced by the
non-genotoxic carcinogen, phenobarbital (PB), were
shown to persist in PB driven tumours, highlighting that
such changes may be early exposure biomarkers [13]. It is
also noteworthy that in age associated DNA methylation
signatures, identified in humans and mice, attenuation of
these changes by altered diet is associated with increased
longevity [11,23]. Thus, it may be possible to decode
5hmC signatures that are unique to a given drug expo-
sure/disease state, in which loci exhibiting reproducible
5hmC changes can be predictive of downstream conse-
quences. 5hmC profiles in circulating cell free DNA can
already aid in the identification of the tissue origin of
tumours based on their abnormal DNA modification
profiles [24]. The large scale application of genome-
wide sequencing approaches in these studies will lead to a
greater understanding of the molecular events occurring
following compound exposure and toxicity, enabling a
more defined study of linkage to disease outcomes.
Studies of DNA methylation patterns following
environmental and chemical exposure events
in humans
The majority of studies interrogating epigenetic response
have been highly targeted approaches, such as locusCurrent Opinion in Chemical Biology 2018, 45:48–56
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Figure 2
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Potential application of epigenetic profiling to chemical challenge studies. A generic experimental design encompassing an overview of the stages
relating to toxicity pathway responses, mode of action pathways (MoAs) and adverse outcome pathways (AOP) — with the examples below of
inorganic arsenite and endocrine disrupting compound (EDCs: Vinclozolin and Triclosan) mediated perturbation of target organs including liver and
CD4+ T-cells.
Current Opinion in Chemical Biology 2018, 45:48–56 www.sciencedirect.com
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Table 1
Environmental and chemical exposure studies.
Exposure Mode of action Areas of uncertainty References
Heavy metals: arsenic, cadmium Differentially methylated regions
detected following exposure in
cultured cells correlate with changes
in gene expression, alternative
splicing, epithelial to mesenchymal
transition; differential methylation in
T-cells; altered p16 expression.
In vivo exposure, dose severity [26,27,48–52]
Airborne aerosols and cigarette
smoke
DNA methylation differences
detected in whole blood DNA after in
vivo exposure locate at CpGs in or
near genes including aryl
hydrocarbon receptor (AHRR)
Variance in exposure levels (i.e.
dose level, frequency of
exposure, chemical composition
differences between exposures)
[29–31,53,54]
Endocrine disrupting chemicals
(EDCs)
Mimic endogenous hormones,
impairing reproduction; nuclear
receptor signalling dependent
activation of liver specific
cytochrome P450 detoxification
enzymes leads to transcriptional
and epigenetic perturbance
Difference between organisms in
their dependencies on
epigenomic pathways
[15,34]
Non-genotoxic-carcinogens:
phenobarbital
Promotes nuclear translocation of
the constitutive androstane receptor
(CAR); changes the epigenome and
transcriptome, leading to liver
cancer (genetic change)
Diversity in MoAs and lack of
genotoxicity make it hard to
predict carcinogenic potential in
short term tests.
[37,38,39]
Germline exposure: vinclozolin,
bisphenol A, or di-(2-ethylhexyl)
phthalate
Changes in transcription and
methylation in fetal cells after
maternal exposure
Differences between studies due
to genetic variability; extent of
transgenerational inheritance
[40,41,44–46]specific sequencing following bisulphite treatment or
candidate locus specific PCR following epigenetic anti-
body enrichment strategies [15,25]. Progress in the
assessment is summarised here and in Table 1.
Arsenic (As) contaminated drinking water at levels
associated with a variety of adverse health effects
and shortened lifespan are consumed by an estimated
200 million people worldwide [26]. The mechanisms
underlying arsenic toxicity are not completely clarified;
however, epigenetic events in concert with epithelial-to-
mesenchymal transformation have been hypothesized to
underpin its MoA [27]. Reduced representative DNA
methylation analysis has identified differentially methyl-
ated (for 5mC and 5hmC) regions between normal and
iAs-transformed cultured cells but further genome-wide
efforts are required to assess in vivo arsenic-exposure
risk, and dose severity, as this strongly impacts upon
the observed epigenetic perturbations [26,28]. For
instance, assessments of in vivo exposure by recent epi-
genome-wide association studies (EWAS) have identified
reproducible, smoking-associated DNA methylation dif-
ferences in whole blood DNA, even from short-term low-
dose exposure [29–31].
The harmful effects of endocrine disrupting chemicals
(EDCs) in the environment are based on their ability to
act as endogenous hormone mimics [15]. Multi-layered
epigenomic analysis combined with toxicologicalwww.sciencedirect.com assessments such as the EDC tests provided by the
Organisation for Economic Co-operation and Develop-
ment (OECD) will improve exposure monitoring and
derive endpoints that are predictive/protective of all life
stages in different organisms, which may have altered
dependencies on epigenomic pathways [32,33]. The
mode of action of EDCs is not only through reproduction
impairments [15]; many liver specific cytochrome P450
detoxification enzymes are induced by and metabolise a
broad range of steroidal and EDC compounds, leading to
perturbed transcriptional and epigenetic outcomes [34].
Recent studies on the antibacterial agent, Triclosan, for
instance suggest it may alter the liver methylome and act
as a tumour promoter [35,36]. Comprehensive epige-
nomic modelling of the effect of toxic compounds and
EDCs on the liver in multiple organisms can therefore
underpin environmental exposure epigenetic studies; a
generic experimental design is outlined in Figure 2.
Studies investigating drug induced epigenetic perturba-
tions have focused on exposure to carcinogenic agents in
rodent bioassays either by genotoxic carcinogens (GCs) or
non-genotoxic carcinogens (NGCs). NGCs are able to
promote carcinogenesis without inducing a direct muta-
tion to the DNA sequence and thus can be viewed as
inducers of changed epigenetic states that are propagated
long after the initial exposure event [13,37]. PB is a well-
established model of a non-genotoxic rodent hepatocar-
cinogen increasing the incidence of spontaneously andCurrent Opinion in Chemical Biology 2018, 45:48–56
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Figure 3
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The methylome as sensor of environmental injury. Numerous natural and non-natural environmental agents have been shown to induce changes in
DNA methylation in various tissues in vivo, some with correlated changes in gene expression (e.g. Cyp2b and PTPRJ). The stable maintenance of
these altered epigenetic patterns (based on Refs. [12,27,29]) ensures that a memory of this exposure remains, long after the initiating signal is
gone. Different colours represent target tissues.chemically induced liver tumours [38]. Previous work has
shown that exposure to certain xenobiotic agents such PB
results in reproducible changes in both the epigenome
and transcriptome in both mouse and rat livers in a time
dependent manner — ultimately resulting in genetically
defined liver tumour formation (Figure 3) [39]. Com-
parative analyses of these omics landscapes provides a
novel insight into the molecular events and perturbation
of gene networks following both acute and chronic expo-
sure events providing early biomarkers for the develop-
ment of AOPs such as tumour formation [13].
Another area that requires deeper study is the analysis of
compounds implicated in germline changes causing trans-
generational outcomes [40,41]. Many groups have shown
that the sperm methylome can be perturbed by environ-
mental influences including diet; however, stochastic
epigenetic variation can affect the mouse sperm methy-
lome to a greater extent than diet and would be hard to
reconcile with specific transgenerational outcomes that
depend on fertilization by a single sperm [42,43]. Vin-
clozolin, an anti-androgenic fungicide, is suggested to
induce transgenerational phenotypes associated with per-
turbed epigenetic profiles [40,41]. However, independent
groups were unable to replicate the phenotypic results
following intraperitoneal or oral exposure routes [44–46],
perhaps due to genetic variability in rat strains and other
factors. In a genome wide methylation study of prosper-
matogonia of male offspring from mothers treated with
vinclozolin, bisphenol A, or di-(2-ethylhexyl)phthalate,
changes in transcription and methylation in the G1 germ-
line observed after EDC exposure did not persist into theCurrent Opinion in Chemical Biology 2018, 45:48–56 G2 germline [47]. This suggests that EDCs can exert
direct epigenetic effects in exposed fetal germ cells, but
these may be corrected by reprogramming events in the
next generation which protect against transgenerational
outcomes.
T-cell methylation as an optimal barcode of
environmental and chemical exposure in
humans
An ideal biomarker should be sensitive, specific, accessi-
ble, cause minimal discomfort to the patient and be robust
to variations in laboratory handling. DNA methylation
fulfils many of these criteria. However, although several
chemical and environmental agents are known to affect
the DNA methylation profiles of mammalian tissues,
profiling in vivo methylation at internal sites of environ-
mental insult is rarely possible. CD4+ T-cells patrol the
entire human body, including the central nervous system,
and upon exposure to their cognate antigen differentiate
into short-lived effector T-cells or long-lived memory T-
cells [55]. Importantly, as the chemical micro-environ-
ment of T-cells at the time of activation can affect their
epigenetic profile [31,48–53,54,56], memory T-cells can
carry epigenetic markers of both the type and location of
exposure to chemical or environmental agents [57,58].
Moreover, as these cells can live for up to 40 years, our
memory T-cell population carries a collective epigenetic
record of our total environmental and chemical exposure
over time (Figure 4).
Several studies have reported consistent alterations in
T-cell methylation resulting from environmental orwww.sciencedirect.com
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Figure 4
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T-cells as sensors and stores of environmental exposure. (a) Upon exposure to their cognate antigen, a small proportion of activated cells
become long-lived, memory T-cells. The specific cell state of each memory T-cell will also reflect the microenvironment in which the exposure
occurred such as the tissue as well as the presence of biologically active chemicals and non-chemical compounds. (b) As memory T-cells are
long-lived (up to 40 years), the combined memory T-cell methylome may be codified as a barcode of all historical exposures in a given individual.
The development of single cell methylome sequencing will allow dissection and resolution of this complex and highly valuable epigenetic record of
environmental insult.chemical exposure to many of the agents reviewed above.
Smoking, air pollution (polycyclic aromatic hydrocarbons,
and ambient fine particles) [31,53], arsenic [48–50], pollen
[54], milk protein [56] and certain vitamins [53] have
been associated with altered CD4+ T-cell methylation, at
the time of exposure and afterwards [54]. The observed
changes in T-cell methylation or in T-cell population
composition may result from direct effects upon the
differentiation program of the T-cells or from their
response to tissue injury, or both. Thus, whereas meth-
ylation profiles of total CD4+ T-cell populations may
identify large changes in DNA methylation induced by
exposure to chemical and non-chemical environmental
agents [54], the ability to profile thousands of single
T-cell methylomes simultaneously will allow identifica-
tion of individual sub-populations of memory T-cells that
may have been affected by different exposures at differ-
ent time points; this complex information may be codified
into an epigenetic barcode of system-wide and organ-
specific historical environmental and chemical exposures
(Figure 4).
Future perspectives
The application of integrated epigenomic and transcrip-
tomic profiling of xenobiotic exposure in animal models
has enabled enhanced mechanistic interpretation andwww.sciencedirect.com novel early biomarker discovery [12,13,59,60]. To assess
the relevance of epigenetic modifications identified in
vitro for drug safety science, it is essential to investigate
such changes in putative target organs in vivo. To deter-
mine the epigenetic changes that signify a toxic response,
one of the future challenges will be in understanding the
mechanisms by which these dynamic multi-dimensional
epigenetic landscapes are regulated and altered in
response to chemical exposure [14]. It is therefore essen-
tial to establish both the dose response, particularly at low
exposures, and reversibility, to aid risk assessment and
dose setting (Figures 2 and 4). Another challenge will be
understanding how toxicant exposure affects the compo-
sition and differentiation status of cell types in a given
tissue — which may be addressed through the adaptation
of new technologies such as single cell transcriptomic and
epigenomic analyses. Progress in these areas will require
interdisciplinary research encompassing toxicology, epi-
genomics data generation, bioinformatics and clinical and
whole animal studies.
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